PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26821066-6	2016	CJ also provoked a slight activation of NF-kappaB, and consistent with this notion a combined treatment of CJ and the NF-kappaB inhibitor parthenolide (Pt) led to a remarkable synergistic cell death in T-ALL cells.	parthenolide	138-150	nuclear factor kappa B subunit 1	Homo sapiens	40-49	
26821066-6	2016	CJ also provoked a slight activation of NF-kappaB, and consistent with this notion a combined treatment of CJ and the NF-kappaB inhibitor parthenolide (Pt) led to a remarkable synergistic cell death in T-ALL cells.	parthenolide	138-150	nuclear factor kappa B subunit 1	Homo sapiens	118-127	
26821066-6	2016	CJ also provoked a slight activation of NF-kappaB, and consistent with this notion a combined treatment of CJ and the NF-kappaB inhibitor parthenolide (Pt) led to a remarkable synergistic cell death in T-ALL cells.	parthenolide	152-154	nuclear factor kappa B subunit 1	Homo sapiens	40-49	
26821066-6	2016	CJ also provoked a slight activation of NF-kappaB, and consistent with this notion a combined treatment of CJ and the NF-kappaB inhibitor parthenolide (Pt) led to a remarkable synergistic cell death in T-ALL cells.	parthenolide	152-154	nuclear factor kappa B subunit 1	Homo sapiens	118-127	
26821066-7	2016	Altogether, our data support the concept that inhibition of the SERCA pump may be a novel strategy for the treatment of T-ALL with HD-domain-mutant Notch1 receptors and that additional treatment with the NF-kappaB inhibitor parthenolide may have further therapeutic benefits.	parthenolide	224-236	nuclear factor kappa B subunit 1	Homo sapiens	204-213